Specializing in low-frequency mutant molecule detection, our top-tier CLIA lab works tirelessly to accelerate your discovery process. Uncover accurate data, found the first time.
SYSMEX x QIAGEN
We joined forces with QIAGEN, another world-class company, to accelerate global CDx access. Our collective expertise allows us to anticipate and understand your specific needs throughout the clinical trial process.
Why Sysmex Inostics?
Sensitivity matters.
It empowers more accurate detection of low-frequency biomarkers from a simple blood draw. Expedite your studies and uncover deeper insights into therapy response. Our testing technologies are optimized for ultra-sensitivity with high specificity and efficiency.